Annual CFO
$19.35 M
+$39.47 M+196.16%
December 31, 2023
Summary
- As of February 7, 2025, CTNM annual cash flow from operations is $19.35 million, with the most recent change of +$39.47 million (+196.16%) on December 31, 2023.
- During the last 3 years, CTNM annual CFO has risen by +$45.62 million (+173.67%).
- CTNM annual CFO is now at all-time high.
Performance
CTNM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$6.17 M
+$2.33 M+27.41%
September 30, 2024
Summary
- As of February 7, 2025, CTNM quarterly cash flow from operations is -$6.17 million, with the most recent change of +$2.33 million (+27.41%) on September 30, 2024.
- Over the past year, CTNM quarterly CFO has increased by +$4.54 million (+42.37%).
- CTNM quarterly CFO is now -115.17% below its all-time high of $40.67 million, reached on June 1, 2023.
Performance
CTNM Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$33.35 M
-$792.00 K-2.43%
September 30, 2024
Summary
- As of February 7, 2025, CTNM TTM cash flow from operations is -$33.35 million, with the most recent change of -$792.00 thousand (-2.43%) on September 30, 2024.
- Over the past year, CTNM TTM CFO has dropped by -$52.70 million (-272.34%).
- CTNM TTM CFO is now -194.12% below its all-time high of $35.43 million, reached on June 1, 2023.
Performance
CTNM TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CTNM Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +196.2% | +42.4% | -272.3% |
| 3 y3 years | +173.7% | - | - |
| 5 y5 years | +173.7% | - | - |
CTNM Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +173.7% | -115.2% | +42.4% | -194.1% | at low |
| 5 y | 5-year | at high | +173.7% | -115.2% | +42.4% | -194.1% | at low |
| alltime | all time | at high | +173.7% | -115.2% | +42.4% | -194.1% | at low |
Contineum Therapeutics Class A Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.17 M(-27.4%) | -$33.35 M(+2.4%) |
| Jun 2024 | - | -$8.50 M(+6.6%) | -$32.55 M(-295.9%) |
| Mar 2024 | - | -$7.97 M(-25.5%) | $16.62 M(-14.1%) |
| Dec 2023 | $19.35 M | -$10.70 M(+99.1%) | $19.35 M(-35.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$5.38 M(-113.2%) | $30.05 M(-15.2%) |
| Jun 2023 | - | $40.67 M(-875.6%) | $35.43 M(-775.6%) |
| Mar 2023 | - | -$5.24 M | -$5.24 M |
| Dec 2022 | -$20.12 M(-23.4%) | - | - |
| Dec 2021 | -$26.27 M | - | - |
FAQ
- What is Contineum Therapeutics Class A annual cash flow from operations?
- What is the all time high annual CFO for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A annual CFO year-on-year change?
- What is Contineum Therapeutics Class A quarterly cash flow from operations?
- What is the all time high quarterly CFO for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A quarterly CFO year-on-year change?
- What is Contineum Therapeutics Class A TTM cash flow from operations?
- What is the all time high TTM CFO for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A TTM CFO year-on-year change?
What is Contineum Therapeutics Class A annual cash flow from operations?
The current annual CFO of CTNM is $19.35 M
What is the all time high annual CFO for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high annual cash flow from operations is $19.35 M
What is Contineum Therapeutics Class A annual CFO year-on-year change?
Over the past year, CTNM annual cash flow from operations has changed by +$39.47 M (+196.16%)
What is Contineum Therapeutics Class A quarterly cash flow from operations?
The current quarterly CFO of CTNM is -$6.17 M
What is the all time high quarterly CFO for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high quarterly cash flow from operations is $40.67 M
What is Contineum Therapeutics Class A quarterly CFO year-on-year change?
Over the past year, CTNM quarterly cash flow from operations has changed by +$4.54 M (+42.37%)
What is Contineum Therapeutics Class A TTM cash flow from operations?
The current TTM CFO of CTNM is -$33.35 M
What is the all time high TTM CFO for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high TTM cash flow from operations is $35.43 M
What is Contineum Therapeutics Class A TTM CFO year-on-year change?
Over the past year, CTNM TTM cash flow from operations has changed by -$52.70 M (-272.34%)